These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20220768)

  • 1. A candidate gene study of CLEC16A does not provide evidence of association with risk for anti-CCP-positive rheumatoid arthritis.
    Bronson PG; Ramsay PP; Seldin MF; Gregersen PK; Criswell LA; Barcellos LF
    Genes Immun; 2010 Sep; 11(6):504-8. PubMed ID: 20220768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis.
    Skinningsrud B; Lie BA; Husebye ES; Kvien TK; Førre Ø; Flatø B; Stormyr A; Joner G; Njølstad PR; Egeland T; Undlien DE
    Ann Rheum Dis; 2010 Aug; 69(8):1471-4. PubMed ID: 19734133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis.
    Poór G; Nagy ZB; Schmidt Z; Brózik M; Merétey K; Gergely P
    Ann N Y Acad Sci; 2007 Sep; 1110():23-32. PubMed ID: 17911417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients.
    Viatte S; Plant D; Bowes J; Lunt M; Eyre S; Barton A; Worthington J
    Ann Rheum Dis; 2012 Dec; 71(12):1984-90. PubMed ID: 22661644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage-inducible C-type lectin is associated with anti-cyclic citrullinated peptide antibodies-positive rheumatoid arthritis in men.
    Wu XY; Guo JP; Yin FR; Lu XL; Li R; He J; Liu X; Li ZG
    Chin Med J (Engl); 2012 Sep; 125(17):3115-9. PubMed ID: 22932191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of CLEC16A region and autoimmune thyroid diseases.
    Muhali FS; Cai TT; Zhu JL; Qin Q; Xu J; He ST; Shi XH; Jiang WJ; Xiao L; Li DF; Zhang JA
    G3 (Bethesda); 2014 Mar; 4(6):973-7. PubMed ID: 24646814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms and functional haplotype in PADI4: further evidence for contribution on rheumatoid arthritis susceptibility and anti-cyclic citrullinated peptide antibodies in a western Mexican population.
    Guzmán-Guzmán IP; Reyes-Castillo Z; Muñoz-Barrios S; Ruiz-Noa Y; Martínez-Bonilla GE; Parra-Rojas I; Palafox-Sánchez CA; Muñoz-Valle JF
    Immunol Lett; 2015 Feb; 163(2):214-20. PubMed ID: 25562673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study.
    Bang SY; Han TU; Choi CB; Sung YK; Bae SC; Kang C
    Arthritis Res Ther; 2010; 12(3):R115. PubMed ID: 20537173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
    Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
    Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More CLEC16A gene variants associated with multiple sclerosis.
    Nischwitz S; Cepok S; Kroner A; Wolf C; Knop M; Müller-Sarnowski F; Pfister H; Rieckmann P; Hemmer B; Ising M; Uhr M; Bettecken T; Holsboer F; Müller-Myhsok B; Weber F
    Acta Neurol Scand; 2011 Jun; 123(6):400-6. PubMed ID: 20849399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of HLA-DRB1 alleles with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in northern east part of Turkey.
    Uçar F; Çapkin E; Karkucak M; Yücel B; Sönmez M; Alver A; Kaklikkaya N; Tosun M; Alemdaroğlu E; Solak M
    Int J Rheum Dis; 2012 Dec; 15(6):538-45. PubMed ID: 23253237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particular association of clinical and genetic features with autoimmunity to citrullinated α-enolase in rheumatoid arthritis.
    Montes A; Dieguez-Gonzalez R; Perez-Pampin E; Calaza M; Mera-Varela A; Gomez-Reino JJ; Gonzalez A
    Arthritis Rheum; 2011 Mar; 63(3):654-61. PubMed ID: 21360494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus.
    Mero IL; Ban M; Lorentzen ÅR; Smestad C; Celius EG; Sæther H; Saeedi H; Viken MK; Skinningsrud B; Undlien DE; Aarseth J; Myhr KM; Granum S; Spurkland A; Sawcer S; Compston A; Lie BA; Harbo HF
    Genes Immun; 2011 Apr; 12(3):191-8. PubMed ID: 21179112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis.
    Cha S; Choi CB; Han TU; Kang CP; Kang C; Bae SC
    Arthritis Rheum; 2007 May; 56(5):1454-63. PubMed ID: 17469103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency.
    Skinningsrud B; Husebye ES; Pearce SH; McDonald DO; Brandal K; Wolff AB; Løvås K; Egeland T; Undlien DE
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3310-7. PubMed ID: 18593762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VAV1 regulates experimental autoimmune arthritis and is associated with anti-CCP negative rheumatoid arthritis.
    Guerreiro-Cacais AO; Norin U; Gyllenberg A; Berglund R; Beyeen AD; ; Petit-Teixeira E; Cornélis F; Saoudi A; Fournié GJ; Holmdahl R; Alfredsson L; Klareskog L; Jagodic M; Olsson T; Kockum I; Padyukov L
    Genes Immun; 2017 Jan; 18(1):48-56. PubMed ID: 28053322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genome-wide association study identifies SLC8A3 as a susceptibility locus for ACPA-positive rheumatoid arthritis.
    Julià A; González I; Fernández-Nebro A; Blanco F; Rodriguez L; González A; Cañete JD; Maymó J; Alperi-López M; Olivé A; Corominas H; Martínez-Taboada V; Erra A; Sánchez-Fernández S; Alonso A; Lopez-Lasanta M; Tortosa R; Codó L; Gelpi JL; García-Montero AC; Bertranpetit J; Absher D; Bridges SL; Myers RM; Tornero J; Marsal S
    Rheumatology (Oxford); 2016 Jun; 55(6):1106-11. PubMed ID: 26983453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Greater prevalence of seropositivity for anti-cyclic citrullinated peptide antibody in unaffected first-degree relatives in multicase rheumatoid arthritis-affected families.
    Kim SK; Bae J; Lee H; Kim JH; Park SH; Choe JY
    Korean J Intern Med; 2013 Jan; 28(1):45-53. PubMed ID: 23345996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication of Associations of Genetic Loci Outside the HLA Region With Susceptibility to Anti-Cyclic Citrullinated Peptide-Negative Rheumatoid Arthritis.
    Viatte S; Massey J; Bowes J; Duffus K; ; Eyre S; Barton A; Worthington J
    Arthritis Rheumatol; 2016 Jul; 68(7):1603-13. PubMed ID: 26895230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.